GREZF yields 3.18% · JNJ yields 2.13%● Live data
📍 GREZF pulled ahead of the other in Year 1
Combined, GREZF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GREZF + JNJ for your $10,000?
GREE, Inc., a technology company, engages in the online media business in Japan and internationally. It operates through Internet and Entertainment, and Investment and Incubation segments. The company provides GREE, a social networking services (SNS) platform, and social games and diverse content closely linked with SNS, offering a variety of entertainment related elements centered on user-to-user communication; and develops and operates app games for smartphones under the GREE, WFS, Pokelabo, and GREE Entertainment brands to app delivery platforms. It also operates REALITY, a metaverse virtual live streaming app; REALITY XR cloud, a cloud solution for virtual events that take place in any virtual space; and REALITY STUDIO, a virtual creative label that has produced a wide variety of talent, including KMNZ, VESPERBELL, and HACHI. In addition, the company operates aumo, a travel and lifestyle information services platform; LIMIA, an on-line magazine that features home and living lifestyle content; MINE, an on-line video magazine that features women's fashion, beauty, and lifestyle topics; and ARINE, an on-line magazine for young women with the latest content on topics. Further, it provides DX support for client business based on experiences and achievements; and produces, develops, and directs anime and manga IP content. Additionally, the company invests in startup companies operating mainly in the Internet and IT fields through venture capital funds or corporate venture capital. GREE, Inc. was founded in 2004 and is headquartered in Tokyo, Japan.
Full GREZF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.